KNBIF (Kane Biotech) Change In Inventory: $-0.23 Mil (TTM As of Mar. 2026)


What is Kane Biotech Change In Inventory?

Kane Biotech KNBIF Change In Inventory is $-0.23 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

Kane Biotech's change in inventory for the quarter that ended in Mar. 2026 was $0.02 Mil. It means Kane Biotech's inventory declined by $0.02 Mil from Dec. 2025 to Mar. 2026 .

Kane Biotech's change in inventory for the fiscal year that ended in Dec. 2025 was $-0.09 Mil. It means Kane Biotech's inventory increased by $0.09 Mil from Dec. 2024 to Dec. 2025 .

Kane Biotech's Total Inventories for the quarter that ended in Mar. 2026 was $0.35 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Kane Biotech's Days Inventory for the quarter that ended in Mar. 2026 was 958.13.

Inventory Turnover measures how fast the company turns over its inventory within a year. Kane Biotech's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.10.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Kane Biotech's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 11.52.

Kane Biotech  (OTCPK:KNBIF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Kane Biotech's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0.357/0.034*365 / 4
=958.13

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Kane Biotech's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0.034 / 0.357
=0.10

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Kane Biotech's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0.357 / 0.031
=11.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Change In Inventory Related Terms

Kane Biotech Change In Inventory Historical Data

* Premium members only.

The historical data trend for Kane Biotech's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Change In Inventory Chart

Kane Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.05 -0.08 -0.09 -0.09

Kane Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 -0.13 -0.00 -0.12 0.02

Kane Biotech Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $-0.23 Mil mean?
Kane Biotech (KNBIF) has a Change In Inventory of $-0.23 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Kane Biotech and its competitors.
Is Kane Biotech's Change In Inventory too high?
Kane Biotech's current Change In Inventory is $-0.23 Mil.
How does Kane Biotech's Change In Inventory compare to VRTX and REGN?
Kane Biotech's Change In Inventory of $-0.23 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Kane Biotech and its competitors. Kane Biotech's current Change In Inventory is $-0.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current Change In Inventory of $-0.23 Mil. The current Change In Inventory is $-0.23 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current Change In Inventory is $-0.23 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.